Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-20

Clinical Trial Update: Gardasil Versus Cervarix in the Treatment of Warts [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Gardasil and Cervarix for treatment of verruca (warts) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cervarix (human papillomavirus vaccine, bivalent)
  • Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Zagazig University | Conditions: Verruca Viral | Phase 3 | Status: COMPLETED